Header Logo

Laura L Holman

TitleProf,Asoc
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentGynecologic Oncology
AddressWP 2410
920 Stanton L Young Blvd
Oklahoma City OK 73104
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Monk BJ, Barretina-Ginesta MP, Pothuri B, Vergote I, Graybill W, Mirza MR, McCormick CC, Lorusso D, Moore RG, Freyer G, O'Cearbhaill RE, Heitz F, O'Malley DM, Redondo A, Shahin MS, Vulsteke C, Bradley WH, Haslund CA, Chase DM, Pisano C, Holman LL, P?rez MJR, DiSilvestro P, Gaba L, Herzog TJ, Bruchim I, Compton N, Shtessel L, Malinowska IA, Gonz?lez-Mart?n A. Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial. Ann Oncol. 2024 Nov; 35(11):981-992. PMID: 39284381.
      Citations:    Fields:    
    2. Brown J, Miller A, Holman LL, Backes F, Nagel C, Bender D, Miller DS, Powell MA, Westin SN, Bonebrake A, Muller CY, Secord AA, Crane E, Schorge J, Tew WP, Sood AK, Bookman MA, Aghajanian C, Gershenson DM. Results of a randomized phase II trial of paclitaxel and carboplatin versus bleomycin, etoposide and cisplatin for newly diagnosed and recurrent Chemonaive stromal ovarian tumors: An NRG oncology/gynecologic oncology group study14. Gynecol Oncol. 2024 Sep 11; 190:283-290. PMID: 39265466.
      Citations:    Fields:    
    3. Pitiyarachchi O, Ansell PJ, Coleman RL, Dinh MH, Holman L, Leath CA, Werner T, DiSilvestro P, Morgan M, Tew W, Lee C, Cunningham M, Newton M, Edraki B, Lim P, Barlin J, Spirtos NM, Tewari KS, Edelson M, Reid T, Carlson J, Friedlander M. Homologous recombination deficiency should be tested for in patients with advanced stage high-grade serous ovarian cancer aged 70?years and over. Gynecol Oncol. 2024 08; 187:221-226. PMID: 38821039.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    4. Klopp AH, Enserro D, Powell M, Randall M, Schink JC, Mannel RS, Holman L, Bender D, Kushnir CL, Backes F, Zweizig SL, Waggoner S, Bradley KA, Lawrence LD, Hanjani P, Darus CJ, Small W, Cardenes HR, Feddock JM, Miller DS. Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial. J Clin Oncol. 2024 Jul 10; 42(20):2425-2435. PMID: 38662968.
      Citations: 1     Fields:    Translation:Humans
    5. Han CY, Lu KH, Corrigan G, Perez A, Kohring SD, Celestino J, Bedi D, Bedia E, Bevers T, Boruta D, Carlson M, Holman L, Leeds L, Mathews C, McCann G, Moore RG, Schlumbrecht M, Slomovitz B, Tobias D, Williams-Brown Y, Bevers MW, Liu J, Gornet TG, Handy BC, Lu Z, Bedia JS, Skates SJ, Bast RC. Normal Risk Ovarian Screening Study: 21-Year Update. J Clin Oncol. 2024 Jan 09; JCO2300141. PMID: 38194613.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    6. Azizoddin DR, Cohn AM, Ulahannan SV, Henson CE, Alexander AC, Moore KN, Holman LL, Boozary LK, Sifat MS, Kendzor DE. Cannabis use among adults undergoing cancer treatment. Cancer. 2023 Jun 24. PMID: 37354093.
      Citations: 5     Fields:    Translation:HumansAnimals
    7. Ade CJ, Dockery L, Walter AC, Benbrook DM, Vesely SK, Hammond ST, Moore KN, Holman LL. Association between Serum Biomarkers with Postoperative Complications and Delay of Adjuvant Chemotherapy Initiation in Ovarian Cancer Patients Undergoing Primary Cytoreductive Surgery: A Pilot Study. Nutr Cancer. 2023; 75(2):662-669. PMID: 36495155; PMCID: PMC10127353.
      Citations: 1     Fields:    Translation:Humans
    8. Jackson CG, Moore KN, Cantrell L, Erickson BK, Duska LR, Richardson DL, Landrum LM, Holman LL, Walker JL, Mannel RS, Moxley KM, Queimado L, Cohoon A, Ding K, Dockery LE. A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium. Gynecol Oncol. 2022 07; 166(1):44-49. PMID: 35491267.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    9. Slomovitz BM, Filiaci VL, Walker JL, Taub MC, Finkelstein KA, Moroney JW, Fleury AC, Muller CY, Holman LL, Copeland LJ, Miller DS, Coleman RL. A randomized phase II trial of everolimus and letrozole or hormonal therapy in women with advanced, persistent or recurrent endometrial carcinoma: A GOG Foundation study. Gynecol Oncol. 2022 03; 164(3):481-491. PMID: 35063278.
      Citations: 21     Fields:    Translation:HumansCTClinical Trials
    10. Levinson K, Beavis AL, Purdy C, Rositch AF, Viswanathan A, Wolfson AH, Kelly MG, Tewari KS, McNally L, Guntupalli SR, Ragab O, Lee YC, Miller DS, Huh WK, Wilkinson KJ, Spirtos NM, Le LV, Casablanca Y, Holman LL, Waggoner SE, Fader AN. Corrigendum to "Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis" [Gynecologic Oncology 162 (2021) 532-538]. Gynecol Oncol. 2021 Dec; 163(3):616-617. PMID: 34654574.
      Citations:    Fields:    
    11. Levinson K, Beavis AL, Purdy C, Rositch AF, Viswanathan A, Wolfson AH, Kelly MG, Tewari KS, McNally L, Guntupalli SR, Ragab O, Lee YC, Miller DS, Huh WK, Wilkinson KJ, Spirtos NM, Van Le L, Casablanca Y, Holman LL, Waggoner SE, Fader AN. Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis. Gynecol Oncol. 2021 09; 162(3):532-538. PMID: 34217544.
      Citations: 15     Fields:    Translation:Humans
    12. Duska LR, Filiaci VL, Walker JL, Holman LL, Hill EK, Moore RG, Ring KL, Pearl ML, Muller CY, Kushnir CL, Lankes HA, Samuelson MI, Carrick KS, Rajan A, Rodgers WH, Kohn EC, Piekarz R, Leslie KK. A Surgical Window Trial Evaluating Medroxyprogesterone Acetate with or without Entinostat in Patients with Endometrial Cancer and Validation of Biomarkers of Cellular Response. Clin Cancer Res. 2021 05 15; 27(10):2734-2741. PMID: 33766814.
      Citations: 9     Fields:    Translation:Humans
    13. Vetter MH, Smrz S, Gehrig PA, Peng K, Matsuo K, Davidson BA, Cisa MP, Lees BF, Brunette LL, Tucker K, Stuart Staley A, Gotlieb WH, Holloway RW, Essel KG, Holman LL, Goldfeld E, Olawaiye A, Rose S, Uppal S, Bixel K. Pathologic and clinical tumor size discordance in early-stage cervical cancer: Does it matter? Gynecol Oncol. 2020 11; 159(2):354-358. PMID: 32888724.
      Citations: 4     Fields:    Translation:Humans
    14. Uppal S, Gehrig PA, Peng K, Bixel KL, Matsuo K, Vetter MH, Davidson BA, Cisa MP, Lees BF, Brunette LL, Tucker K, Stuart Staley A, Gotlieb WH, Holloway RW, Essel KG, Holman LL, Goldfeld E, Olawaiye A, Rose SL. Recurrence Rates in Patients With Cervical Cancer Treated With Abdominal Versus Minimally Invasive Radical Hysterectomy: A Multi-Institutional Retrospective Review Study. J Clin Oncol. 2020 04 01; 38(10):1030-1040. PMID: 32031867.
      Citations: 57     Fields:    Translation:Humans
    15. Perkins V, Moore K, Vesely S, Matsuo K, Mostofizadeh S, Sims TT, Lea J, Barnes D, Chen S, Carlson M, Roman L, Monk BJ, Holman LL. Incorporation of whole pelvic radiation into treatment of stage IVB cervical cancer: A novel treatment strategy. Gynecol Oncol. 2020 01; 156(1):100-106. PMID: 31810653.
      Citations: 9     Fields:    Translation:Humans
    16. Lebok P, Zuna RE, Holman LL, Young RH. Multiple Luteinized Follicle Cysts of the Ovary in a Patient With a Pituitary Adenoma: Report of a Case and Review of the Literature. Int J Gynecol Pathol. 2019 Nov; 38(6):562-567. PMID: 30358638.
      Citations:    Fields:    Translation:Humans
    17. Prendergast EN, Holman LL, Liu AY, Lai TS, Campos MP, Fahey JN, Wang X, Abdelaal N, Rao JY, Elvin JA, Moore KM, Konecny GE, Cohen JG. Comprehensive genomic profiling of recurrent endometrial cancer: Implications for selection of systemic therapy. Gynecol Oncol. 2019 09; 154(3):461-466. PMID: 31257009.
      Citations: 9     Fields:    Translation:Humans
    18. Matsuo K, Machida H, Blake EA, Holman LL, Rimel BJ, Roman LD, Wright JD. Trends and outcomes of women with synchronous endometrial and ovarian cancer. Oncotarget. 2018 Jun 19; 9(47):28757-28771. PMID: 29983894.
      Citations: 17     Fields:    
    19. Nebgen DR, Hurteau J, Holman LL, Bradford A, Munsell MF, Soletsky BR, Sun CC, Chisholm GB, Lu KH. Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: A pilot study in women with BRCA1/2 mutations. Gynecol Oncol. 2018 07; 150(1):79-84. PMID: 29735278.
      Citations: 23     Fields:    Translation:Humans
    20. Dockery LE, Motwani A, Ding K, Doescher M, Dvorak JD, Moore KN, Holman LL. Improving cancer care for American Indians with cervical cancer in the Indian Health Service (IHS) system - Navigation may not be enough. Gynecol Oncol. 2018 04; 149(1):89-92. PMID: 29605056.
      Citations: 7     Fields:    Translation:Humans
    21. Castellano T, Moore KN, Holman LL. An Overview of Immune Checkpoint Inhibitors in Gynecologic Cancers. Clin Ther. 2018 03; 40(3):372-388. PMID: 29530456.
      Citations: 8     Fields:    Translation:Humans
    22. Holman LL, Pal N, Iglesias DA, Soliman PT, Balakrishnan N, Klopp A, Broaddus RR, Fleming ND, Munsell MF, Lu KH, Westin SN. Factors prognostic of survival in advanced-stage uterine serous carcinoma. Gynecol Oncol. 2017 07; 146(1):27-33. PMID: 28465008.
      Citations: 14     Fields:    Translation:Humans
    23. Deel CD, Allen RA, Holman LL, Zuna RE. Adenocarcinoma of the cervix involving the fallopian tube mucosa: report of a case. Diagn Pathol. 2016 Aug 17; 11(1):77. PMID: 27530463.
      Citations: 9     Fields:    Translation:Humans
    24. Slaughter K, Holman LL, Thomas EL, Gunderson CC, Lauer JK, Ding K, McMeekin DS, Moore KM. Primary and acquired platinum-resistance among women with high grade serous ovarian cancer. Gynecol Oncol. 2016 08; 142(2):225-30. PMID: 27208536.
      Citations: 19     Fields:    Translation:Humans
    25. Holman LL, Ren Y, Westin SN. Status epilepticus associated with platinum chemotherapy in a patient with cervical cancer: a case report. BMC Cancer. 2015 Oct 17; 15:728. PMID: 26474752.
      Citations: 2     Fields:    Translation:Humans
    26. Brown J, Taylor K, Ramirez PT, Sun C, Holman LL, Cone SM, Irwin J, Frumovitz M. Laparoscopic supracervical hysterectomy with morcellation: should it stay or should it go? J Minim Invasive Gynecol. 2015 Feb; 22(2):185-92. PMID: 25242233.
      Citations: 5     Fields:    Translation:Humans
    27. Eskander RN, Osann K, Dickson E, Holman LL, Rauh-Hain JA, Spoozak L, Wu E, Krill L, Fader AN, Tewari KS. Assessment of palliative care training in gynecologic oncology: a gynecologic oncology fellow research network study. Gynecol Oncol. 2014 Aug; 134(2):379-84. PMID: 24887355.
      Citations: 5     Fields:    Translation:Humans
    28. Holman LL, Friedman S, Daniels MS, Sun CC, Lu KH. Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers. Gynecol Oncol. 2014 May; 133(2):283-6. PMID: 24582866.
      Citations: 27     Fields:    Translation:Humans
    29. Holman LL, Levenback CF, Frumovitz M. Sentinel lymph node evaluation in women with cervical cancer. J Minim Invasive Gynecol. 2014 Jul-Aug; 21(4):540-5. PMID: 24407177.
      Citations: 19     Fields:    Translation:Humans
    30. Holman LL, Lu KH, Bast RC, Hernandez MA, Bodurka DC, Skates S, Sun CC. Risk perception, worry, and test acceptance in average-risk women who undergo ovarian cancer screening. Am J Obstet Gynecol. 2014 Mar; 210(3):257.e1-6. PMID: 24246524.
      Citations: 4     Fields:    Translation:Humans
    31. Holman LL, Lu KH. Genetic risk and gynecologic cancers. Hematol Oncol Clin North Am. 2012 Feb; 26(1):13-29. PMID: 22244659.
      Citations: 2     Fields:    Translation:Humans
    32. Robison K, Holman LL, Moore RG. Update on sentinel lymph node evaluation in gynecologic malignancies. Curr Opin Obstet Gynecol. 2011 Feb; 23(1):8-12. PMID: 21235023.
      Citations: 2     Fields:    Translation:Humans
    33. Matteson KA, Phipps MG, Raker CA, Cronin B, Holman L. Discussion: 'Treatment of symptomatic uterine fibroids' by van der Kooij et al. Am J Obstet Gynecol. 2010 Aug; 203(2):e1-6. PMID: 20659601.
      Citations: 2     Fields:    Translation:Humans
    Holman's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (158)
    Explore
    _
    Co-Authors (17)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _